![John E. Hesketh](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John E. Hesketh
Oprichter bij Uni Targeting Research AS
Actieve functies van John E. Hesketh
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Uni Targeting Research AS
![]() Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Oprichter | 30-07-2009 | - |
Corporate Officer/Principal | 28-07-2009 | - | |
Newcastle University | Corporate Officer/Principal | 28-07-2009 | - |
University of Natural Resources & Life Sciences | Corporate Officer/Principal | - | - |
Loopbaan van John E. Hesketh
Statistieken
Internationaal
Noorwegen | 2 |
Verenigd Koninkrijk | 2 |
Oostenrijk | 2 |
Operationeel
Corporate Officer/Principal | 3 |
Founder | 1 |
Sectoraal
Consumer Services | 3 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Uni Targeting Research AS
![]() Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Health Technology |
- Beurs
- Insiders
- John E. Hesketh
- Ervaring